Europe PMCopen access
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy
PTEN, Biomarker, prostate cancer, Pi3k/akt, Akt Inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 478501
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.